Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P L Turecek

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Thrombosis and Haemostasis|January 5, 2002
Thrombin-mediated in vitro processing of pro-von Willebrand factorK Váradi, P L Turecek, A Mitterer, et al.
Biotechniques|April 19, 2000
Sensitive single-stage PCR using custom-synthesized internal controlsK Zimmermann, M Rieger, P Gross, et al.
Thrombosis and Haemostasis|December 29, 2000
Characterization of antibodies induced by human factor VIII in a murine knockout model of hemophilia AB M Reipert, R U Ahmad, P L Turecek, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 30, 2015
Safety of PEGylated recombinant human full-length coagulation factor VIII (BAX 855) in the overall context of PEG and PEG conjugatesR Stidl, S Fuchs, M Bossard, et al.
Thrombosis and Haemostasis|December 29, 1999
Phospholipid-bound tissue factor modulates both thrombin generation and APC-mediated factor Va inactivationK Váradi, J Siekmann, P L Turecek, et al.
Thrombosis and Haemostasis|December 14, 1999
Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP)H E Gerritsen, P L Turecek, H P Schwarz, et al.
Thrombosis and Haemostasis|March 1, 1997
Assessment of bleeding for the evaluation of therapeutic preparations in small animal models of antibody-induced hemophilia and von Willebrand diseaseP L Turecek, H Gritsch, G Richter, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 17, 2016
Pro- and anticoagulant factors facilitate thrombin generation and balance the haemostatic response to FEIBA(®) in prophylactic therapyK Varadi, S Tangada, M Loeschberger, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 24, 1999
Evaluation of recombinant von Willebrand factor in a canine model of von Willebrand diseaseH P Schwarz, F Dorner, A Mitterer, et al.
Vox Sanguinis|October 26, 1999
Factor Xa and prothrombin: mechanism of action of FEIBAP L Turecek, K Varadi, H Gritsch, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Thrombosis and Haemostasis|January 5, 2002
Thrombin-mediated in vitro processing of pro-von Willebrand factorK Váradi, P L Turecek, A Mitterer, et al.
Biotechniques|April 19, 2000
Sensitive single-stage PCR using custom-synthesized internal controlsK Zimmermann, M Rieger, P Gross, et al.
Thrombosis and Haemostasis|December 29, 2000
Characterization of antibodies induced by human factor VIII in a murine knockout model of hemophilia AB M Reipert, R U Ahmad, P L Turecek, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 30, 2015
Safety of PEGylated recombinant human full-length coagulation factor VIII (BAX 855) in the overall context of PEG and PEG conjugatesR Stidl, S Fuchs, M Bossard, et al.
Thrombosis and Haemostasis|December 29, 1999
Phospholipid-bound tissue factor modulates both thrombin generation and APC-mediated factor Va inactivationK Váradi, J Siekmann, P L Turecek, et al.
Thrombosis and Haemostasis|December 14, 1999
Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP)H E Gerritsen, P L Turecek, H P Schwarz, et al.
Thrombosis and Haemostasis|March 1, 1997
Assessment of bleeding for the evaluation of therapeutic preparations in small animal models of antibody-induced hemophilia and von Willebrand diseaseP L Turecek, H Gritsch, G Richter, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 17, 2016
Pro- and anticoagulant factors facilitate thrombin generation and balance the haemostatic response to FEIBA(®) in prophylactic therapyK Varadi, S Tangada, M Loeschberger, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 24, 1999
Evaluation of recombinant von Willebrand factor in a canine model of von Willebrand diseaseH P Schwarz, F Dorner, A Mitterer, et al.
Vox Sanguinis|October 26, 1999
Factor Xa and prothrombin: mechanism of action of FEIBAP L Turecek, K Varadi, H Gritsch, et al.
Pageof 6